Dr. Robert L. Cowie reviews medical content for
Healthwise, a nonprofit organization with a mission to help people make better
health decisions. Dr. Cowie, a specialist in respiratory medicine, is a
professor at the University of Calgary in the Departments of Medicine and
Community Health Sciences. He is a member of the Division of Respiratory
Medicine of the University of Calgary and the Calgary Health Region. In
addition, Dr. Cowie is director of Tuberculosis Services of the Calgary Health
Region and director of the Calgary COPD and Asthma Program. He has also been a
staff physician with the Department of Medicine at Foothills Hospital in
Calgary since 1990.
His career as a teacher, writer, and
researcher makes him a sought-after speaker addressing clinical and research
groups throughout North America, South Africa, and Europe.
Dr.
Cowie has written numerous scientific research studies and textbooks focusing
on asthma, tuberculosis, and occupational lung epidemiology. In 2002, he
received the Alberta Lung Association Award of Excellence, a Lorraine
Award.
Healthwise Knowledgebase Topics Reviewed
Professional Affiliations
Selected Publications
- Cowie RL, Sharpe JW (1998). Tuberculosis in immigrants: Interval
from arrival in Canada to diagnosis: A five year study in southern Alberta.
Canadian Medical Association Journal, 158(5):
599–602.
- Cowie RL, Underwood MF, Little CB, Mitchell I, Spier S,
Fort GT (2002). Asthma in adolescents: A randomised controlled trial of an
asthma program for adolescents and young adults with severe asthma.
Canadian Respiratory Journal, 9(4):
253–259.
- Cowie RL, Underwood MF, Field SK (2004). Inhaled
corticosteroid therapy does not control asthma. Canadian Respiratory Journal, 11(8): 555–558.
- Cowie RL, Underwood
MF, Field SK (2007). Asthma symptoms do not predict spirometry. Canadian Respiratory Journal, 14(6):
339–342.
- Cowie RL, Field SK, Fanning EA (2007). Nontuberculous
mycobacteria. In R Long, E Ellis, eds., Canadian Tuberculosis Standards, 6th ed., pp. 221–236.
Financial Disclosure
Dr. Cowie has served on
advisory boards and/or received fees for presentations from GlaxoSmithKline,
AstraZeneca, Merck Frosst (Canada), Nycomed, Novartis, and Boehringer
Ingelheim.